FDA Grants Investigational Device Exemption for Afib Study

  AtriCure said has won an investigational device exemption from the FDA for a first-of-its-kind clinical trial involving patients with non-paroxysmal atrial fibrillation, according to MassDevice.  The trial will combine ablation outside the heart and...

There is No Such Thing as “Low Hanging Fruit” in Drug R&D

Forbes just posted this thought-provoking article written by the former President of Pfizer Global Research.  Using an approach Merck attempted as an example, he discusses some of the challenges that decision makers face these days in relation to drug safety,...